Biotech
GSK Shifts Strategy, Axes Adult Vaccine Candidate in $2.1B Affinivax Deal Amid Rising Competition
In a strategic shift, GSK has halted the development of its 24-valent pneumococcal vaccine for adults—a major project from its...
Read more
How South Africa’s Virtualmedx is Transforming Healthcare Access Across Africa
South African e-health startup Virtualmedx is making strides toward bridging the divide between patients and healthcare professionals across the African...
Read more
BioNTech Expands African mRNA Vaccine Operations with $145M CEPI Funding for Rwanda Facility
As BioNTech navigates the challenges of a post-pandemic landscape, the German biotech giant has strengthened its commitment to advancing mRNA...
Read more
GSK Invests $300M in Next-Generation Lupus Drug from Chimagen Biosciences
Building on its legacy as a leader in lupus treatment, GlaxoSmithKline (GSK) is making a substantial investment in a new...
Read more
Neurocrine and Idorsia End Partnership Following Phase 2 Trial Failures of Epilepsy Drug
After two years and multiple unsuccessful trials, Neurocrine Biosciences and Swiss biotech Idorsia have officially ended their collaboration on NBI-827104,...
Read more
Novartis Faces Setback with MorphoSys Acquisition as Safety Concerns Delay Key Drug Approval Plans
In a turn of events that could reshape Novartis' $2.9 billion acquisition of German biotech MorphoSys, the Swiss pharmaceutical giant...
Read more
Monte Rosa Therapeutics Secures $150M Partnership with Novartis for Autoimmune Treatment
Monte Rosa Therapeutics, a Boston-based biotechnology firm, has struck a significant deal with Novartis, securing $150 million for its innovative...
Read more
YC Startup Pharos lands a $5M Seed led by Felicis to bring AI to Hospital Quality Reporting
Medical and administrative staff are increasingly overwhelmed with piles of paperwork they have to fill out every day. Dozens, if...
Read more
